Back to search
A phase 2 study of an allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer (HRPC)
Data up to Jan 2025
Published2004
Citations43
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database